Unicycive Therapeutics, Inc. received a notice from Nasdaq stating that they were not in compliance with the minimum market value and minimum bid price requirements, but they have since regained compliance.
AI Assistant
UNICYCIVE THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.